December 14, 2018

Pan-Canadian radiotherapy group advancing care by reducing barriers to conducting clinical trials

Stereotactic radiation for treatment of a lung cancer: This precise technique delivers high doses of very conformal radiation in only a few sessions and is being tested in a CAPRI trial. Areas receiving high doses of radiation are shown in red, and lower doses of radiation are shown in blue.

As a radiation oncologist at the London Health Sciences Centre, Dr. David Palma is on the front lines of treating cancer patients with radiotherapy. Despite huge advances in radiation technology over the past few decades, Palma and his colleagues have noticed that clinical trials proving the benefits of these new technologies are not keeping pace – meaning these advances are not always reaching patients. To overcome these challenges and advance treatment, Palma formed the Canadian Pulmonary Radiotherapy Investigators Group (CAPRI) to support radiotherapy clinical trials and get them up and running as quickly as possible.

Continue reading – Pan-Canadian radiotherapy group advancing care by reducing barriers to conducting clinical trials